Antithrombotic therapy in COVID-19 patients

Antithrombotic therapy in COVID-19 patients

Recently, there have been published the data of large randomized trials on the use of antithrombotic agents for reducing a risk of thromboembolic complications, multiple organ failure and mortality in COVID-19 patients. However, principles of selecting optimal therapy remain open. Strategies for the...

Full description

Bibliographic Details
Main Authors: E. V. Slukhanchuk, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, A. S. Shkoda, D. V. Blinov, V. I. Tsibizova, Z. Jinbo, S. Sheena, S. Sсhulman, J.-K. Gris, I. Elalamy, A. D. Makatsariya
Format: Article
Language:Russian
Published: IRBIS LLC 2023-01-01
Series:Акушерство, гинекология и репродукция
Subjects:
coronavirus
severe acute respiratory syndrome
sars-cov-2
antithrombotic therapy
antiaggregants
anticoagulants
covid-19
Online Access:https://www.gynecology.su/jour/article/view/1521

Similar Items

Similar Items